Inventor · disambiguated record
Lukas C. Amler
Also filed as: AMLER LUKAS · AMLER LUKAS C
6 granted patents·10 pending applications·96 citations·filing 2003–2017
81Inventor score
Top patents by PatentIndex Score
16 records- 0195US7981418B2Predicting response to a HER inhibitorGENENTECH INC·Filed 2008·Granted Jul 19, 2011·68 cites·64 claims
- 0291US8940302B2Predicting response to a HER inhibitorGENENTECH INC·Filed 2012·Granted Jan 27, 2015·17 cites·23 claims
- 0385US7537891B2Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cellsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 26, 2009·8 cites·1 claims
- 0470US7504211B2Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cellsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 17, 2009·3 cites·1 claims
- 0562US2015111211A1Predicting response to a her inhibitorGENENTECH INC·Filed 2014·Application pending·0 cites
- 0660US2013095172A1Uses for and article of manufacture including her2 dimerization inhibitor pertuzumabGENENTECH INC·Filed 2012·Application pending·0 cites
- 0758US2016175438A1Uses for and article of manufacture including her2 dimerization inhibitor pertuzumabGENENTECH INC·Filed 2016·Application pending·0 cites
- 0857US11021711B2Genetic variations associated with drug resistanceGENENTECH INC·Filed 2017·Granted Jun 1, 2021·0 cites·8 claims
- 0955US2006121044A1Selecting patients for therapy with a her inhibitorGENENTECH INC·Filed 2005·Application pending·0 cites
- 1054US2011246399A1Predicting response to a her inhibitorGENENTECH INC·Filed 2011·Application pending·0 cites
- 1154US2011245103A1Predicting response to a her inhibitorGENENTECH INC·Filed 2011·Application pending·0 cites
- 1253US2008317753A1Selecting patients for therapy with a her inhibitorGENENTECH INC·Filed 2008·Application pending·0 cites
- 1350US9879267B2Genetic variations associated with drug resistanceLACKNER MARK·Filed 2009·Granted Jan 30, 2018·0 cites·2 claims
- 1444US2013259867A1Diagnosis and treatments relating to her3 inhibitorsGENENTECH INC·Filed 2013·Application pending·0 cites
- 1544US2008038271A1Extending survival of cancer patients with elevated levels of EGF or TGF-alphaAMLER LUKAS C·Filed 2007·Application pending·0 cites
- 1641US2006234237A1Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulatorsAMLER LUKAS C·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →